Abstract
Escherichia coli has been most widely used for production of the recombinant proteins. Over-expression of the recombinant proteins is the mainspring of the inclusion bodies formation. The refolding of these proteins into bioactive forms is cumbersome and partly time-consuming. In the present study, we reviewed and discussed most issues regarding the recovery of “classical inclusion bodies” by focusing on our previous experiences. Performing proper methods of expression, solubilization, refolding and final purification of these proteins, would make it possible to recover higher amounts of proteins into the native form with appropriate conformation. Generally, providing mild conditions and proper refolding buffers, would lead to recover more than 40% of inclusion bodies into bioactive and native conformation.
Keywords: Inclusion body, mild solubilization, native-like secondary structure, protein refolding, purification, recombinant expression.
Graphical Abstract
[1]
Sonnendecker C, Wei R, Kurze E, Wang J, Oeser T, Zimmermann W. Efficient extracellular recombinant production and purification of a Bacillus cyclodextrin glucanotransferase in Escherichia coli. Microb Cell Fact 2017; 16(1): 87.
[http://dx.doi.org/10.1186/s12934-017-0701-1]
[http://dx.doi.org/10.1186/s12934-017-0701-1]
[2]
Park AR, Jang SW, Kim JS, Park YG, Koo BS, Lee HC. Efficient recovery of recombinant CRM197 expressed as inclusion bodies in E. coli. PLoS One 2018; 13(7): e0201060.
[http://dx.doi.org/10.1371/journal.pone.0201060]
[http://dx.doi.org/10.1371/journal.pone.0201060]
[3]
Baneyx F. Recombinant protein expression in Escherichia coli. Curr Opin Biotechnol 1999; 10(5): 411-21.
[http://dx.doi.org/10.1016/S0958-1669(99)00003-8]
[http://dx.doi.org/10.1016/S0958-1669(99)00003-8]
[4]
Swartz JR. Advances in Escherichia coli production of therapeutic proteins. Curr Opin Biotechnol 2001; 12(2): 195-201.
[http://dx.doi.org/10.1016/S0958-1669(00)00199-3]
[http://dx.doi.org/10.1016/S0958-1669(00)00199-3]
[5]
Qin HM, Wang JW, Guo Q, et al. Refolding of a novel cholesterol oxidase from Pimelobacter simplex reveals dehydrogenation activity. Protein Expr Purif 2017; 139: 1-7.
[http://dx.doi.org/10.1016/j.pep.2017.07.008]
[http://dx.doi.org/10.1016/j.pep.2017.07.008]
[6]
Walsh G. Biopharmaceutical benchmarks 2014. Nat Biotechnol 2014; 32(10): 992-1000.
[http://dx.doi.org/10.1038/nbt.3040]
[http://dx.doi.org/10.1038/nbt.3040]
[7]
Jürgen B, Breitenstein A, Urlacher V, et al. Quality control of inclusion bodies in Escherichia coli. Microb Cell Fact 2010; 9: 41.
[http://dx.doi.org/10.1186/1475-2859-9-41]
[http://dx.doi.org/10.1186/1475-2859-9-41]
[8]
Hoffmann D, Ebrahimi M, Gerlach D, Salzig D, Czermak P. Reassessment of inclusion body-based production as a versatile opportunity for difficult-to-express recombinant proteins. Crit Rev Biotechnol 2018; 38(5): 729-44.
[http://dx.doi.org/10.1080/07388551.2017.1398134]
[http://dx.doi.org/10.1080/07388551.2017.1398134]
[9]
Ehgartner D, Sagmeister P, Langemann T, Meitz A, Lubitz W, Herwig C. A novel method to recover inclusion body protein from recombinant E. coli fed-batch processes based on phage ΦX174-derived lysis protein E. Appl Microbiol Biotechnol 2017; 101(14): 5603-14.
[http://dx.doi.org/10.1007/s00253-017-8281-x]
[http://dx.doi.org/10.1007/s00253-017-8281-x]
[10]
Palmer I, Wingfield PT. Preparation and extraction of insoluble (inclusion-body) proteins from Escherichia coli. Curr Protoc Protein Sci 2004; Chapter 6: Unit 6.3.
[11]
Singhvi P, Saneja A, Srichandan S, Panda AK. Bacterial inclusion bodies: A treasure trove of bioactive proteins. Trends Biotechnol 2020; 38(5): 474-86.
[http://dx.doi.org/10.1016/j.tibtech.2019.12.011]
[http://dx.doi.org/10.1016/j.tibtech.2019.12.011]
[12]
Panda AK, Singhvi PVU. Recovery of bioactive protein from inclusion bodies using mild solubilisation agent. J Transm Dis Immun 2018; p. 74.
[13]
Upadhyay V, Singh A, Jha D, Singh A, Panda AK. Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent. Microb Cell Fact 2016; 15: 100.
[http://dx.doi.org/10.1186/s12934-016-0504-9]
[http://dx.doi.org/10.1186/s12934-016-0504-9]
[14]
Upadhyay V, Singh A, Panda AK. Purification of recombinant ovalbumin from inclusion bodies of Escherichia coli. Protein Expr Purif 2016; 117: 52-8.
[http://dx.doi.org/10.1016/j.pep.2015.09.015]
[http://dx.doi.org/10.1016/j.pep.2015.09.015]
[15]
Singh A, Upadhyay V, Upadhyay AK, Singh SM, Panda AK. Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process. Microb Cell Fact 2015; 14: 41.
[http://dx.doi.org/10.1186/s12934-015-0222-8]
[http://dx.doi.org/10.1186/s12934-015-0222-8]
[16]
Singh A, Upadhyay V, Panda AK. Solubilization and refolding of inclusion body proteins. Methods Mol Biol 2015; 1258: 283-91.
[http://dx.doi.org/10.1007/978-1-4939-2205-5_15]
[http://dx.doi.org/10.1007/978-1-4939-2205-5_15]
[17]
Nand KN, Gupta JC, Panda AK, Jain SK. Development of a recombinant hCG-specific single chain immunotoxin cytotoxic to hCG expressing cancer cells. Protein Expr Purif 2015; 106: 10-7.
[http://dx.doi.org/10.1016/j.pep.2014.10.008]
[http://dx.doi.org/10.1016/j.pep.2014.10.008]
[18]
Panda AK. Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli. Adv Biochem Eng Biotechnol 2003; 85: 43-93.
[http://dx.doi.org/10.1007/3-540-36466-8_3]
[http://dx.doi.org/10.1007/3-540-36466-8_3]
[19]
Khan RH, Rao KB, Eshwari AN, Totey SM, Panda AK. Solubilization of recombinant ovine growth hormone with retention of native-like secondary structure and its refolding from the inclusion bodies of Escherichia coli. Biotechnol Prog 1998; 14(5): 722-8.
[http://dx.doi.org/10.1021/bp980071q]
[http://dx.doi.org/10.1021/bp980071q]
[20]
Patra AK, Mukhopadhyay R, Mukhija R, Krishnan A, Garg LC, Panda AK. Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli. Protein Expr Purif 2000; 18(2): 182-92.
[http://dx.doi.org/10.1006/prep.1999.1179]
[http://dx.doi.org/10.1006/prep.1999.1179]
[21]
Patra AK, Gahlay GK, Reddy BV, Gupta SK, Panda AK. Refolding, structural transition and spermatozoa-binding of recombinant bonnet monkey (Macaca radiata) zona pellucida glycoprotein-C expressed in Escherichia coli. Eur J Biochem 2000; 267(24): 7075-81.
[http://dx.doi.org/10.1046/j.1432-1327.2000.01808.x]
[http://dx.doi.org/10.1046/j.1432-1327.2000.01808.x]
[22]
Raina K, Panda AK, Ali MM, Talwar GP. Purification, refolding, and characterization of recombinant LHRH-T multimer. Protein Expr Purif 2004; 37(1): 8-17.
[http://dx.doi.org/10.1016/j.pep.2004.03.008]
[http://dx.doi.org/10.1016/j.pep.2004.03.008]
[23]
Panda AK, Sheikh MG, Eshwari ANS, Garg L. Process for solubilization of recombinant proteins expressed as inclusion body. US20040235089A1, November 25, 2004.
[24]
Slouka C, Kopp J, Hutwimmer S, et al. Custom made inclusion bodies: Impact of classical process parameters and physiological parameters on inclusion body quality attributes. Microb Cell Fact 2018; 17(1): 148.
[http://dx.doi.org/10.1186/s12934-018-0997-5]
[http://dx.doi.org/10.1186/s12934-018-0997-5]
[25]
Kumar S, Jain KK, Singh A, Panda AK, Kuhad RC. Characterization of recombinant pectate lyase refolded from inclusion bodies generated in E. coli BL21(DE3). Protein Expr Purif 2015; 110: 43-51.
[http://dx.doi.org/10.1016/j.pep.2014.12.003]
[http://dx.doi.org/10.1016/j.pep.2014.12.003]
[26]
Singh SM, Sharma A, Upadhyay AK, Singh A, Garg LC, Panda AK. Solubilization of inclusion body proteins using n-propanol and its refolding into bioactive form. Protein Expr Purif 2012; 81(1): 75-82.
[http://dx.doi.org/10.1016/j.pep.2011.09.004]
[http://dx.doi.org/10.1016/j.pep.2011.09.004]
[27]
Jong WS, Vikström D, Houben D, van den Berg van Saparoea HB, de Gier JW, Luirink J. Application of an E. coli signal sequence as a versatile inclusion body tag. Microb Cell Fact 2017; 16(1): 50.
[http://dx.doi.org/10.1186/s12934-017-0662-4]
[http://dx.doi.org/10.1186/s12934-017-0662-4]
[28]
Berks BC. The twin-arginine protein translocation pathway. Annu Rev Biochem 2015; 84: 843-64.
[http://dx.doi.org/10.1146/annurev-biochem-060614-034251]
[http://dx.doi.org/10.1146/annurev-biochem-060614-034251]
[29]
Singh SM, Panda AK. Solubilization and refolding of bacterial inclusion body proteins. J Biosci Bioeng 2005; 99(4): 303-10.
[http://dx.doi.org/10.1263/jbb.99.303]
[http://dx.doi.org/10.1263/jbb.99.303]
[30]
Wang X, Zhou B, Hu W, Zhao Q, Lin Z. Formation of active inclusion bodies induced by hydrophobic self-assembling peptide GFIL8. Microb Cell Fact 2015; 14(1): 88.
[http://dx.doi.org/10.1186/s12934-015-0270-0]
[http://dx.doi.org/10.1186/s12934-015-0270-0]
[31]
Khow O, Suntrarachun S. Strategies for production of active eukaryotic proteins in bacterial expression system. Asian Pac J Trop Biomed 2012; 2(2): 159-62.
[http://dx.doi.org/10.1016/S2221-1691(11)60213-X]
[http://dx.doi.org/10.1016/S2221-1691(11)60213-X]
[32]
Hwang PM, Pan JS, Sykes BD. Targeted expression, purification, and cleavage of fusion proteins from inclusion bodies in Escherichia coli. FEBS Lett 2014; 588(2): 247-52.
[http://dx.doi.org/10.1016/j.febslet.2013.09.028]
[http://dx.doi.org/10.1016/j.febslet.2013.09.028]
[33]
Athey J, Alexaki A, Osipova E, et al. A new and updated resource for codon usage tables. BMC Bioinformatics 2017; 18(1): 391.
[http://dx.doi.org/10.1186/s12859-017-1793-7]
[http://dx.doi.org/10.1186/s12859-017-1793-7]
[34]
Li H, Hao C, Xu D. Development of a novel vector for cloning and expressing extremely toxic genes in Escherichia coli. Electron J Biotechnol 2017; 30: 88-94.
[http://dx.doi.org/10.1016/j.ejbt.2017.10.004]
[http://dx.doi.org/10.1016/j.ejbt.2017.10.004]
[35]
Hajihassan Z, Biroonro N. Enhanced expression of recombinant activin A in Escherichia coli by optimization of induction parameters. J Sci. Islamic Repub Iran 2018; 29(2): 105-11.
[36]
Rosano GL, Ceccarelli EA. Recombinant protein expression in Escherichia coli: Advances and challenges. Front Microbiol 2014; 5(172): 172.
[http://dx.doi.org/10.3389/fmicb.2014.00172]
[http://dx.doi.org/10.3389/fmicb.2014.00172]
[37]
Jia B, Jeon CO. High-throughput recombinant protein expression in Escherichia coli: current status and future perspectives. Open Biol 2016; 6(8): 160196.
[http://dx.doi.org/10.1098/rsob.160196]
[http://dx.doi.org/10.1098/rsob.160196]
[38]
Singh A, Upadhyay V, Upadhyay AK, Singh SM, Panda AK. Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process. Microb Cell Fact 2015; 14(1): 41.
[http://dx.doi.org/10.1186/s12934-015-0222-8]
[http://dx.doi.org/10.1186/s12934-015-0222-8]
[39]
Qi X, Sun Y, Xiong S. A single freeze-thawing cycle for highly efficient solubilization of inclusion body proteins and its refolding into bioactive form. Microb Cell Fact 2015; 14: 24.
[http://dx.doi.org/10.1186/s12934-015-0208-6]
[http://dx.doi.org/10.1186/s12934-015-0208-6]
[40]
Tao H, Liu W, Simmons BN, Harris HK, Cox TC, Massiah MA. Purifying natively folded proteins from inclusion bodies using sarkosyl, Triton X-100, and CHAPS. Biotechniques 2010; 48(1): 61-4.
[http://dx.doi.org/10.2144/000113304]
[http://dx.doi.org/10.2144/000113304]
[41]
Upadhyay AK, Murmu A, Singh A, Panda AK. Kinetics of inclusion body formation and its correlation with the characteristics of protein aggregates in Escherichia coli. PLoS One 2012; 7(3): e33951.
[http://dx.doi.org/10.1371/journal.pone.0033951]
[http://dx.doi.org/10.1371/journal.pone.0033951]
[42]
Pechsrichuang P, Songsiriritthigul C, Haltrich D, et al. OmpA signal peptide leads to heterogenous secretion of B. subtilis chitosanase enzyme from E. coli expression system. Springerplus 2016; 5(1): 1200.
[http://dx.doi.org/10.1186/s40064-016-2893-y]
[http://dx.doi.org/10.1186/s40064-016-2893-y]
[43]
Esmaili I, Mohammad Sadeghi HM, Akbari V. Effect of buffer additives on solubilization and refolding of reteplase inclusion bodies. Res Pharm Sci 2018; 13(5): 413-21.
[http://dx.doi.org/10.4103/1735-5362.236834]
[http://dx.doi.org/10.4103/1735-5362.236834]
[44]
Upadhyay AK, Singh A, Mukherjee KJ, Panda AK. Refolding and purification of recombinant L-asparaginase from inclusion bodies of E. coli into active tetrameric protein. Front Microbiol 2014; 5: 486.
[http://dx.doi.org/10.3389/fmicb.2014.00486]
[http://dx.doi.org/10.3389/fmicb.2014.00486]
[46]
Fischer B, Perry B, Sumner I, Goodenough P. A novel sequential procedure to enhance the renaturation of recombinant protein from Escherichia coli inclusion bodies. Protein Eng 1992; 5(6): 593-6.
[http://dx.doi.org/10.1093/protein/5.6.593]
[http://dx.doi.org/10.1093/protein/5.6.593]
[47]
Klingstedt T, Blechschmidt C, Nogalska A, et al. Luminescent conjugated oligothiophenes for sensitive fluorescent assignment of protein inclusion bodies. ChemBioChem 2013; 14(5): 607-16.
[http://dx.doi.org/10.1002/cbic.201200731]
[http://dx.doi.org/10.1002/cbic.201200731]
[48]
Pandey N, Sachan A, Chen Q, et al. Screening and identification of genetic loci involved in producing more/denser inclusion bodies in Escherichia coli. Microb Cell Fact 2013; 12: 43.
[http://dx.doi.org/10.1186/1475-2859-12-43]
[http://dx.doi.org/10.1186/1475-2859-12-43]
[49]
Yamaguchi H, Miyazaki M. Refolding techniques for recovering biologically active recombinant proteins from inclusion bodies. Biomolecules 2014; 4(1): 235-51.
[http://dx.doi.org/10.3390/biom4010235]
[http://dx.doi.org/10.3390/biom4010235]
[50]
Paraskevopoulou V, Falcone FH. Polyionic Tags as enhancers of protein solubility in recombinant protein expression. Microorganisms 2018; 6(2): E47.
[http://dx.doi.org/10.3390/microorganisms6020047]
[http://dx.doi.org/10.3390/microorganisms6020047]
[51]
Kötzler MP, McIntosh LP, Withers SG. Refolding the unfoldable: A systematic approach for renaturation of Bacillus circulans xylanase. Protein Sci 2017; 26(8): 1555-63.
[http://dx.doi.org/10.1002/pro.3181]
[http://dx.doi.org/10.1002/pro.3181]
[52]
Klint JK, Senff S, Saez NJ, et al. Production of recombinant disulfide-rich venom peptides for structural and functional analysis via expression in the periplasm of E. coli. PLoS One 2013; 8(5): e63865.
[http://dx.doi.org/10.1371/journal.pone.0063865]
[http://dx.doi.org/10.1371/journal.pone.0063865]
[53]
Ryu J, Lee U, Park J, Yoo DH, Ahn JH. A vector system for ABC transporter-mediated secretion and purification of recombinant proteins in Pseudomonas species. Appl Environ Microbiol 2015; 81(5): 1744-53.
[http://dx.doi.org/10.1128/AEM.03514-14]
[http://dx.doi.org/10.1128/AEM.03514-14]
[54]
Wang HZ, Chu ZZ, Chen CC, et al. Recombinant passenger proteins can be conveniently purified by one-step affinity chromatography. PLoS One 2015; 10(12): e0143598.
[http://dx.doi.org/10.1371/journal.pone.0143598]
[http://dx.doi.org/10.1371/journal.pone.0143598]
[55]
Saraswat M, Musante L, Ravidá A, Shortt B, Byrne B, Holthofer H. Preparative purification of recombinant proteins: Current status and future trends. BioMed Res Int 2013; 2013: 312709.
[http://dx.doi.org/10.1155/2013/312709]
[http://dx.doi.org/10.1155/2013/312709]
[56]
Leibly DJ, Nguyen TN, Kao LT, Hewitt SN, Barrett LK, Van Voorhis WC. Stabilizing additives added during cell lysis aid in the solubilization of recombinant proteins. PLoS One 2012; 7(12): e52482.
[57]
López-Villamizar I, Cabezas A, Pinto RM, et al. The Characterization of Escherichia coli CpdB as a recombinant protein reveals that, besides having the expected 3´-nucleotidase and 2´,3´-cyclic mononucleotide phosphodiesterase activities, it is also active as cyclic dinucleotide phosphodiesterase. PLoS One 2016; 11(6): e0157308.
[http://dx.doi.org/10.1371/journal.pone.0157308]
[http://dx.doi.org/10.1371/journal.pone.0157308]
[58]
Vieira Gomes AM, Souza Carmo T, Silva Carvalho L, Mendonça Bahia F, Parachin NS. Comparison of yeasts as hosts for recombinant protein production. Microorganisms 2018; 6(2): E38.
[http://dx.doi.org/10.3390/microorganisms6020038]
[http://dx.doi.org/10.3390/microorganisms6020038]
Related Books
Industrial Applications of Soil Microbes
Genome Editing in Bacteria (Part 2)
Aromatherapy: The Science of Essential Oils
In Vitro Propagation and Secondary Metabolite Production from Medicinal Plants: Current Trends (Part 2)
Micropropagation of Medicinal Plants
Software and Programming Tools in Pharmaceutical Research
Biotechnology and Drug Development for Targeting Human Diseases
In Vitro Propagation and Secondary Metabolite Production from Medicinal Plants: Current Trends (Part 1)
Molecular and Physiological Insights into Plant Stress Tolerance and Applications in Agriculture- Part 2
Micropropagation of Medicinal Plants
Article Metrics
154
4